ALKBH5 was demonstrated to be upregulated in some cancers, such as glioblastoma stem cells [66, 67], breast cancer stem cells [68], colorectal cancer, esophageal cancer, thyroid cancer, gastric cancer, acute myeloid leukemia, and prostate adenocarcinomas [68–70]. Here, ALKBH5 is linked to cancer.